Bakhu Holdings, Corp. Reports Earnings Results for the Full Year Ended July 31, 2020
November 13, 2020 at 02:41 pm
Share
Bakhu Holdings, Corp. announced earnings results for the full year ended July 31, 2020. For the full year, the company announced operating loss was USD 1.089 million compared to USD 10.651 million a year ago. Net loss was USD 1.106 million compared to USD 10.651 million a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.06 a year ago.
Bakhu Holdings, Corp. is a development-stage company. The Company hold a license from Cell Science to plant cell-extraction and replication technology and related equipment, processes, and formulations (the Licensed Science), to produce, manufacture, and sell cannabis-related byproducts - sometimes referred to as cannabinoids in North America, Central America, and the Caribbean for medical, food additive, and recreational uses. The Company is focused on testing and commercializing cannabis plant cell-extraction and replication technologies under a technology license granted by Cell Science. It also intends to sublicense the Licensed Science to third party sub-licensees. The Company has not generated any revenue.
BAKHU HOLDINGS, CORP. 
